The latest market report published by Acute Market Reports, Inc. “Anticoagulants Reversal Drugs Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global anticoagulants reversal drugs market expected to expand at a CAGR of 15.3% from 2018 to 2026.
Browse the full report at https://bit.ly/2CLqgII
The global anticoagulant reversal drugs market is poised to grow during the forecast period owing to
In terms of geography, North America held the largest share in the global anticoagulant reversal drugs market owing to increased approvals and increasing research and development by major pharmaceutical companies in the region. Europe also a held a significant share in the global market attributable to product approvals. Growing incidence of uncontrollable bleeding episodes and usage of anticoagulants will further drive the market in the North America and Europe. U.S. emerged as the largest country level market due to efficient reimbursement scenario of for drugs, high cost of the recently approved drugs and accelerated drug approval initiative by U.S. Food and Drug Administration (FDA) to drive the market. Asia Pacific is set to grow at fastest rate during the forecast period, driven by rising patient population for diseases such as atrial fibrillation, strokes and other cardiopulmonary diseases. Ongoing trials in the region will further stimulate the market growth in the region. The key players currently engaged in anticoagulant reversal drugs market include Boehringer Ingelheim GmbH, Fresenius Kabi AG, Bausch Health Companies, Inc., CSL Behring Limited, Octapharma AG, Portola Pharmaceuticals, Inc., Perosphere Pharmaceuticals, Inc. and Ferring Pharmaceuticals.
Key Market Movements:
- Strong pipeline for anticoagulant reversal drugs in North America and Europe to drive the market during the forecast period
- Growing research and development by pharmaceutical players further boost market growth
- Rising incidence of uncontrollable bleeding episodes and emergency situation due to use of anticoagulants